It has been suggested that genetic variations, including single nucleotide polymorphisms (SNPs) in the ACE2 gene, may account for the differences in symptoms and severities seen in COVID-19 patients, leading to altered immune responses and greater viral susceptibility. The gene discussed is ACE2; the disease is COVID-19.